Physician profile
Amanda Mitchell Hale
NPI 1053937755
$1,678.32
in general payments reported to CMS, 2019-2025
16 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $407 · 2022: $370 · 2023: $413 · 2024: $352 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $443.02 | 2021-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $308.48 | 2022-2024 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $147.43 | 2021-2024 | Gardasil 9, Vaxelis, Gardasil |
| Corium, LLC | $131.03 | 2022-2024 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $119.75 | 2021-2022 | |
| Indivior INC. | $114.05 | 2024-2025 | Sublocade |
| Pfizer INC. | $102.20 | 2021-2023 | |
| Vanda Pharmaceuticals INC. | $68.29 | 2024-2025 | Fanapt, Hetlioz |
| Alkermes, INC. | $57.03 | 2024-2025 | Vivitrol |
| Tris Pharma INC | $44.19 | 2021-2022 | |
| Sobi, INC | $42.20 | 2023 | |
| Seqirus USA INC | $30.96 | 2023-2024 | Flucelvax, Flucelvax Quadrivalent |
| Astrazeneca Pharmaceuticals LP | $20.64 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $19.93 | 2023 | Crysvita |
| Adlon Therapeutics L.P. | $15.98 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $13.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Hale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.